Human Herpesviruses at Sixes, Sevens, and More

  1. Caroline Breese Hall, MD
  1. University of Rochester School of Medicine and Dentistry; Rochester, NY 14642 Grant Support: In part by grant RO1 A 133020-02 from the National Institutes of Allergy and Infectious Diseases.

    In the past decade, the family circle of human herpesviruses (HHVs) has expanded to include three new numbers: HHV-6, −7,and −8.Although each was initially discovered in adults, their reputation, relevance, and renitence begin in infancy.

    Techniques developed to study HIV infection revealed the existence of HHV-6. Initially found in the lymphocytes of patients with AIDS and lymphoproliferative diseases, this novel virus bore a familial resemblance to the herpesviruses and was adopted as their sixth member [1]. Composed of a large double-stranded DNA, DNA polymerase (but not thymidine kinase), and several important glycoproteins, HHV-6 can infect many types of cell but, like HIV, primarily affects CD4 cells. As with other herpesviruses, persistence or latency occurs; genomic material can then be detected in peripheral blood lymphocytes, secretions, and cerebrospinal fluid in healthy and immunosuppressed persons.

    Human herpesvirus-6 actually comprises nearly identical twins, HHV-6A and HHV-6B. The genomic homogeneity of these variants is about 95%, but they differ in antigenicity; cell tropism; epidemiology; and, possibly, pathogenicity [2]. Human herpesvirus-6A was isolated first, and A strains have been recovered primarily from adults, especially immunosuppressed patients. Overall, however, HHV-6B isolates predominate. Human herpesvirus-6B is essentially the sole variant isolated from children with primary infection, and a direct causal relation with disease has been established for the B variant [2-4]. In adults, the quandary is whether the presence of HHV-6 is latent or causes disease. Adding to the mystery is the paucity of reports to date of primary infection with variant A.

    The many miens and mimicries of HHV-6 are just beginning to be recognized. Seroepidemiologic studies quickly indicated universal acquisition during infancy: All newborns possess maternally derived antibody to HHV-6 that decreases to a nadir after several months [4]. This is followed by natural infection that proceeds over the next few …

    This 100-word excerpt has been provided in the absence of an abstract.

    | Table of Contents
    Most Read Most Read
    Most Commented Most Commented On
    Annals in the News Annals in the News
    Clinical Trials Clinical Trials
    Comparative Effectiveness Comparative Effectiveness
    Hospital Medicine Hospital Medicine
    • Advertisement
    • Advertisement